Combination of methylprednisolone and rosiglitazone promotes recovery of neurological function after spinal cord injury

Combination of methylprednisolone and rosiglitazone promotes recovery of neurological function after spinal cord injury

Methylprednisolone exhibits anti-inflammatory antioxidant properties, and rosiglitazone acts as an anti-inflammatory and antioxidant by activating peroxisome proliferator-activated receptor-γ in the spinal cord. Methylprednisolone and rosiglitazone have been clinically used during the early stages o...

Full description

Bibliographic Details
Main Authors: Xi-gong Li, Xiang-jin Lin, Jun-hua Du, San-zhong Xu, Xian-feng Lou, Zhong Chen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Neural Regeneration Research
Subjects:
nerve regeneration; spinal cord injury; methylprednisolone; rosiglitazone; inflammation; drug therapy; anti-inflammatory agents; functional recovery; neural regeneration
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=10;spage=1678;epage=1684;aulast=Li

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2016;volume=11;issue=10;spage=1678;epage=1684;aulast=Li

Similar Items